Filing Details

Accession Number:
0001209191-14-012245
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-20 14:59:13
Reporting Period:
2014-02-18
Filing Date:
2014-02-20
Accepted Time:
2014-02-20 14:59:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574139 Sas Partners Sofinnova 16-18 Rue De 4 Septembre
Paris I0 75002
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-18 1,614,382 $0.00 1,614,382 No 4 C Direct
Common Stock Acquisiton 2014-02-18 260,340 $0.00 1,874,722 No 4 C Direct
Common Stock Acquisiton 2014-02-18 230,769 $13.00 2,105,491 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2014-02-18 13,124,932 $0.00 1,614,382 $0.00
Common Stock Series B Preferred Stock Disposition 2014-02-18 2,116,562 $0.00 260,340 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Every 8.13 shares of Series A Preferred Stock automatically converted into 1 share of Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  2. Every 8.13 shares of Series B Preferred Stock automatically converted into 1 share of Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  3. The shares were purchased at the Issuer's initial public offering.